Oncology & Cancer

New drug shrinks brain tumours in melanoma patients

(Medical Xpress)—Australian researchers have given hope to patients with advanced melanoma by showing that a new drug targeting a common mutation in melanoma successfully shrank tumours that had spread to the brain.

Oncology & Cancer

Birth control device cuts cancer risk: study

Intra-uterine devices designed to prevent conception may also protect against cervical cancer, according to a study covering more than 20,000 women that was released on Tuesday.

Oncology & Cancer

Chernobyl, 25 Years Later: Lessons for Japan?

On the 25th anniversary of the Chernobyl nuclear disaster, a comment published by Lancet Oncology describes the known health consequences of the 1986 event. The authors are Kirsten B. Moysich, PhD, MS, and Philip McCarthy, ...

Oncology & Cancer

Radiation plus hormone therapy greatly improves survival

Men with locally advanced or high-risk prostate cancer who receive combined radiation and hormone therapy live longer and are less likely to die from their disease, shows clinical research led by radiation oncologists at ...

Oncology & Cancer

Ipilimumab active in advanced melanoma with brain mets

(HealthDay) -- For some patients with advanced melanoma and brain metastases, ipilimumab is active, according to the results of a phase 2 study published online March 27 in The Lancet Oncology.

page 3 from 12